Related references
Note: Only part of the references are listed.TLX-Its Emerging Role for Neurogenesis in Health and Disease
Praveen K. Sobhan et al.
MOLECULAR NEUROBIOLOGY (2017)
Revisions to the International Neuroblastoma Response Criteria: A Consensus Statement From the National Cancer Institute Clinical Trials Planning Meeting
Julie R. Park et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
The MYCN Protein in Health and Disease
Maria Victoria Ruiz-Perez et al.
GENES (2017)
Morphological Differentiation Towards Neuronal Phenotype of SH-SY5Y Neuroblastoma Cells by Estradiol, Retinoic Acid and Cholesterol
Heidi Teppola et al.
NEUROCHEMICAL RESEARCH (2016)
Regulation of Nuclear Hormone Receptors by MYCN-Driven miRNAs Impacts Neural Differentiation and Survival in Neuroblastoma Patients
Diogo Ribeiro et al.
CELL REPORTS (2016)
Neuroblastoma
Katherine K. Matthay et al.
NATURE REVIEWS DISEASE PRIMERS (2016)
Nuclear receptors and Drosophila neuronal remodeling
Ana Boulanger et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS (2015)
Coalition of Nuclear Receptors in the Nervous System
Benjamin Foerthmann et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2015)
Neuroblastoma Paradigm for Precision Medicine
Meredith S. Irwin et al.
PEDIATRIC CLINICS OF NORTH AMERICA (2015)
Expression of estrogen and progesterone receptors across human malignancies: new therapeutic opportunities
J. Munoz et al.
CANCER AND METASTASIS REVIEWS (2015)
BRCA1 And Estrogen/Estrogen Receptor In Breast Cancer: Where They Interact?
Li Wang et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2014)
Mechanisms of neuroblastoma regression
Garrett M. Brodeur et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2014)
Oestradiol signalling through the Akt-mTORC1-S6K1
O. Varea et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2013)
MYC inhibition induces metabolic changes leading to accumulation of lipid droplets in tumor cells
Hanna Zirath et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Neuroblastoma and MYCN
Miller Huang et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2013)
Estrogen receptors and human disease: an update
Katherine A. Burns et al.
ARCHIVES OF TOXICOLOGY (2012)
Choosing between glycolysis and oxidative phosphorylation: A tumor's dilemma?
Caroline Jose et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS (2011)
Cancer Invasion and the Microenvironment: Plasticity and Reciprocity
Peter Friedl et al.
CELL (2011)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
Preclinical Models for Neuroblastoma: Establishing a Baseline for Treatment
Tal Teitz et al.
PLOS ONE (2011)
The MYCN oncogene and differentiation in neuroblastoma
Ulrica K. Westermark et al.
SEMINARS IN CANCER BIOLOGY (2011)
MYCN-regulated microRNAs repress estrogen receptor-α (ESR1) expression and neuronal differentiation in human neuroblastoma
Jakob Loven et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Comprehensive characterization of neuroblastoma cell line subtypes reveals bilineage potential similar to neural crest stem cells
Sandra Acosta et al.
BMC DEVELOPMENTAL BIOLOGY (2009)
Trk Receptor Expression and Inhibition in Neuroblastomas
Garrett M. Brodeur et al.
CLINICAL CANCER RESEARCH (2009)
Expression of estrogen receptor-alpha and -beta and progesterone receptor-A and -B in a large cohort of patients with endometrioid endometrial cancer
Vincent Jongen et al.
GYNECOLOGIC ONCOLOGY (2009)
Long-Term Results for Children With High-Risk Neuroblastoma Treated on a Randomized Trial of Myeloablative Therapy Followed by 13-cis-Retinoic Acid: A Children's Oncology Group Study
Katherine K. Matthay et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
The International Neuroblastoma Risk Group (INRG) Classification System: An INRG Task Force Report
Susan L. Cohn et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Central nervous system-specific knockout of steroidogenic factor 1
Ki Woo Kim et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2009)
Anchorage-independent cell growth signature identifies tumors with metastatic potential
S. Mori et al.
ONCOGENE (2009)
Estradiol Activates β-Catenin Dependent Transcription in Neurons
Olga Varea et al.
PLOS ONE (2009)
Normal and cancer-related functions of the p160 steroid receptor co-activator (SRC) family
Jianming Xu et al.
NATURE REVIEWS CANCER (2009)
High Myc pathway activity and low stage of neuronal differentiation associate with poor outcome in neuroblastoma
Erik Fredlund et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Estrogen receptors and human disease
BJ Deroo et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
Estrogen alters TrkA and p75 neurotrophin receptor expression within sympathetic neurons
W Hasan et al.
JOURNAL OF NEUROBIOLOGY (2005)
Genomic analysis of the nuclear receptor family: New insights into structure, regulation, and evolution from the rat genome
ZD Zhang et al.
GENOME RESEARCH (2004)
Neuroblastoma: biology and molecular and chromosomal pathology
M Schwab et al.
LANCET ONCOLOGY (2003)
Neuroblastoma: Biological insights into a clinical enigma
GM Brodeur
NATURE REVIEWS CANCER (2003)
Estrogen-mediated neuroprotection against β-amyloid toxicity requires expression of estrogen receptor α or β and activation of the MAPK pathway
JL Fitzpatrick et al.
JOURNAL OF NEUROCHEMISTRY (2002)
Estrogen treatment suppresses forebrain p75 neurotrophin receptor expression in aged, noncycling female rats
SE Ping et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2002)
Estrogen effects on neurite outgrowth and cytoskeletal gene expression in ERα-transfected PC12 cell lines
L Gollapudi et al.
EXPERIMENTAL NEUROLOGY (2001)
Nerve growth factor signaling, neuroprotection, and neural repair
MV Sofroniew et al.
ANNUAL REVIEW OF NEUROSCIENCE (2001)
Favorable biology and outcome of stage IV-S neuroblastoma with supportive care or minimal therapy: A Children's Cancer Group study
HJ Nickerson et al.
JOURNAL OF CLINICAL ONCOLOGY (2000)
Share Paper
